The use of the Psychiatric Electroencephalography Evaluation Registry (PEER) to personalize pharmacotherapy
Dan V Iosifescu,1 Robert J Neborsky,2–4 Robert J Valuck5–7 1Adult Psychopharmacology Program, Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 2School of Medicine, University of California, San Diego, CA, USA; 3University of California, Los...
Guardado en:
Autores principales: | Iosifescu DV, Neborsky RJ, Valuck RJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a66b6c7e65449ba8d160e01666bda91 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Letter to the editor regarding the article “The use of Psychiatric Electroencephalography Evaluations Registry (PEER) to personalize pharmacotherapy”
por: Weina PJ, et al.
Publicado: (2017) -
Prediction of Suicidality According to Serum Folate Levels in Depressive Patients Receiving Stepwise Pharmacotherapy
por: Jae-Min Kim, et al.
Publicado: (2021) -
¿Es efectivo que los antidepresivos aumentan el riesgo de suicidio?
por: Silva,Hernán, et al.
Publicado: (2007) -
Measuring severe adverse events and medication selection using a “PEER Report” for nonpsychotic patients: a retrospective chart review
por: Hoffman DA, et al.
Publicado: (2012) -
Mobile Electroencephalography for Studying Neural Control of Human Locomotion
por: Seongmi Song, et al.
Publicado: (2021)